1211589

Mark A. Stein, Ph.D. — FEI 3025983703

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
August 4, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Seattle, WA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance